1117 related articles for article (PubMed ID: 26767993)
1. Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis): A systematic review of randomized controlled trials.
Fitzcharles MA; Baerwald C; Ablin J; Häuser W
Schmerz; 2016 Feb; 30(1):47-61. PubMed ID: 26767993
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoids for fibromyalgia.
Walitt B; Klose P; Fitzcharles MA; Phillips T; Häuser W
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011694. PubMed ID: 27428009
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies].
Petzke F; Enax-Krumova EK; Häuser W
Schmerz; 2016 Feb; 30(1):62-88. PubMed ID: 26830780
[TBL] [Abstract][Full Text] [Related]
4. Efficacy, Tolerability, and Safety of Cannabinoid Treatments in the Rheumatic Diseases: A Systematic Review of Randomized Controlled Trials.
Fitzcharles MA; Ste-Marie PA; Häuser W; Clauw DJ; Jamal S; Karsh J; Landry T; Leclercq S; Mcdougall JJ; Shir Y; Shojania K; Walsh Z
Arthritis Care Res (Hoboken); 2016 May; 68(5):681-8. PubMed ID: 26548380
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review].
Volz MS; Siegmund B; Häuser W
Schmerz; 2016 Feb; 30(1):37-46. PubMed ID: 26809974
[TBL] [Abstract][Full Text] [Related]
6. [Cannabinoids in palliative care: Systematic review and meta-analysis of efficacy, tolerability and safety].
Mücke M; Carter C; Cuhls H; Prüß M; Radbruch L; Häuser W
Schmerz; 2016 Feb; 30(1):25-36. PubMed ID: 26809975
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials.
Lynch ME; Campbell F
Br J Clin Pharmacol; 2011 Nov; 72(5):735-44. PubMed ID: 21426373
[TBL] [Abstract][Full Text] [Related]
8. [Opioids in chronic osteoarthritis pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration].
Schaefert R; Welsch P; Klose P; Sommer C; Petzke F; Häuser W
Schmerz; 2015 Feb; 29(1):47-59. PubMed ID: 25376547
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness of cannabinoids in the management of chronic nonmalignant neuropathic pain: a systematic review.
Boychuk DG; Goddard G; Mauro G; Orellana MF
J Oral Facial Pain Headache; 2015; 29(1):7-14. PubMed ID: 25635955
[TBL] [Abstract][Full Text] [Related]
10. Efficacy, tolerability and safety of cannabis-based medicines for cancer pain : A systematic review with meta-analysis of randomised controlled trials.
Häuser W; Welsch P; Klose P; Radbruch L; Fitzcharles MA
Schmerz; 2019 Oct; 33(5):424-436. PubMed ID: 31073761
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
Whiting PF; Wolff RF; Deshpande S; Di Nisio M; Duffy S; Hernandez AV; Keurentjes JC; Lang S; Misso K; Ryder S; Schmidlkofer S; Westwood M; Kleijnen J
JAMA; 2015 Jun 23-30; 313(24):2456-73. PubMed ID: 26103030
[TBL] [Abstract][Full Text] [Related]
12. Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies.
Stockings E; Campbell G; Hall WD; Nielsen S; Zagic D; Rahman R; Murnion B; Farrell M; Weier M; Degenhardt L
Pain; 2018 Oct; 159(10):1932-1954. PubMed ID: 29847469
[TBL] [Abstract][Full Text] [Related]
13. A Systematic Review of Fibromyalgia and Recent Advancements in Treatment: Is Medicinal Cannabis a New Hope?
Khurshid H; Qureshi IA; Jahan N; Went TR; Sultan W; Sapkota A; Alfonso M
Cureus; 2021 Aug; 13(8):e17332. PubMed ID: 34567876
[TBL] [Abstract][Full Text] [Related]
14. Yoga for rheumatic diseases: a systematic review.
Cramer H; Lauche R; Langhorst J; Dobos G
Rheumatology (Oxford); 2013 Nov; 52(11):2025-30. PubMed ID: 23934220
[TBL] [Abstract][Full Text] [Related]
15. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews.
Häuser W; Petzke F; Fitzcharles MA
Eur J Pain; 2018 Mar; 22(3):455-470. PubMed ID: 29034533
[TBL] [Abstract][Full Text] [Related]
17. Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta-analysis.
Meng H; Johnston B; Englesakis M; Moulin DE; Bhatia A
Anesth Analg; 2017 Nov; 125(5):1638-1652. PubMed ID: 28537982
[TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Medicinal Cannabis in the Treatment of Fibromyalgia: A Systematic Review.
Kurlyandchik I; Tiralongo E; Schloss J
J Altern Complement Med; 2021 Mar; 27(3):198-213. PubMed ID: 33337931
[No Abstract] [Full Text] [Related]
19. Chondroitin for osteoarthritis.
Singh JA; Noorbaloochi S; MacDonald R; Maxwell LJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD005614. PubMed ID: 25629804
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Aviram J; Samuelly-Leichtag G
Pain Physician; 2017 Sep; 20(6):E755-E796. PubMed ID: 28934780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
